Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01974609
Other study ID # Narcotic vs. Non-narcotic Pain
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date March 2016
Est. completion date February 24, 2022

Study information

Verified date February 2022
Source Horizon Health Network
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purposes of this noninferiority randomized clinical trial are to: 1. determine whether the most commonly used commonly used non-narcotic analgesic (ibuprofen 600 mg + acetaminophen 325 mg) provides pain relief that is not unacceptably worse than the most commonly prescribed narcotic containing analgesic (hydrocodone 5 mg. + acetaminophen 325 mg, equivalent to Norco 5/325) in patients undergoing carpal tunnel release. 2. Determine whether the following covariates affect pain level following surgery or medication usage: gender, country (US/Canada), pre-operative CTS symptoms, site, workers compensation status and employment status (employed/self-employed/unemployed-able to work/unemployed-unable to work)


Description:

Participants will be provided with forms by site coordinators and will be provided in person instruction on how to fill out the pain intensity scores, the pain interference scores, the pain medication diary, and the final pain relief assessment form. Medications will be identified only by number and will be available to the participant after standard instruction on use of medications is provided by the surgeon or research associate. Patients will be instructed - verbally and written - to take the study medication (2 capsules per dose) up to four times per day as needed for pain for 1 week or until pain free. If patients experience intolerable discomfort, they will be able to contact personnel (24 hours on call) associated with the study to receive an alternate analgesic. The surgeon will determine if the patient is taking the maximum dose and then prescribe additional study drug or a non-study drug as an alternative. If the patient receives pain medication outside of the study protocol, the medication will be recorded, this will be recorded as a protocol violation. If this occurs in more than 20 people during the trial a per-protocol and efficacy analysis will be considered. Participants will return to see the surgeon or designate between post-operative day 7 and 14 to return their diary, unused medication, and post-operative pain satisfaction survey. Participants will be specifically asked about: any adverse events, compliance with the program and the reason for any deviation and any other analgesic medication taken during the course of the study.


Recruitment information / eligibility

Status Completed
Enrollment 347
Est. completion date February 24, 2022
Est. primary completion date February 24, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - All patients undergoing elective a primary carpal tunnel release will be considered eligible Exclusion Criteria: - Patients wil be excluded for any of the following: - previously enrolled in this study (for carpal tunnel surgery on the other hand); - history of chronic opioid use; - documented or suspected substance abuse; - individuals currently on daily use of ibuprofen, acetaminophen or other pain altering medication including medications like Neurontin (gabapentin) and Ultram (tramadol) - individuals with documented or suspected chronic pain syndrome; - reported allergy or adverse reaction to hydrocodone, acetaminophen, or ibuprofen; - those with a history or symptoms of any significant medical problem in the last year (i.e., arrhythmia, impaired cardiovascular function, gastrointestinal bleeding, liver disease, renal disease); - patients with active peptic ulcer disease (history of severe heartburn); - symptoms of infection with initial enrollment; - pregnant or lactating women; - those with a diagnosis of cognitive impairment; - patients unable or unwilling to provide informed consent for surgery or enrollment in a clinical trial; - patients unable or unwilling to fill out the forms or understand the consent form - prior carpal tunnel surgery on the hand to be operated on - individuals currently taking Coumadin, Plavix, or medications that increase bleeding; or - patients with other medical or psychological health conditions that preclude then from receiving either intervention or returning for follow-up visits

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Narcotic
Hydrocodone 5mg + acetaminophen 325 mg
non-narcotic
ibuprofen 600mg + acetaminophen 325 mg

Locations

Country Name City State
Canada Lawson Health Research Institute London Ontario
Canada University of Western Ontario, Canada London Ontario
Canada McGill University Montreal Quebec
Canada Horizon Health Network Saint John New Brunswick
United States The Philadelphia Hand Center Philadelphia Pennsylvania
United States CarilionClinic Roanoke Virginia
United States Sanford orthopedics and Sports Medicine-Sioux Falls Sioux Falls South Dakota

Sponsors (8)

Lead Sponsor Collaborator
Horizon Health Network Carilion Clinic, Jefferson Medical College of Thomas Jefferson University, Lawson Health Research Institute, McGill University, Sanford Health, University of Michigan, University of Western Ontario, Canada

Countries where clinical trial is conducted

United States,  Canada, 

References & Publications (1)

Lalonde DH, Lalonde JF, MacDermid JC, Chung KC, Gan BS, Mierisch C, Van Demark RE Jr, Luc M. Time to Stop Routinely Prescribing Opiates after Carpal Tunnel Release. Plast Reconstr Surg. 2022 Mar 1;149(3):651-660. doi: 10.1097/PRS.0000000000008834. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain relief 1. Determine whether the most commonly used nonnarcotic analgesics (ibuprofen 600 mg + acetaminophen 325 mg) provide pain relief that is not unacceptably worse than the most commonly prescribed narcotic containing analgesic (hydrocodone 5 mg + acetaminophen 325 mg, equivalent to Norco® 5/325) in patients undergoing carpal tunnel release. 7-15 days
See also
  Status Clinical Trial Phase
Completed NCT02219555 - DUCATS Trial: Dynamic Ultrasound to Enhance Understanding of Carpal Tunnel Syndrome
Completed NCT05697276 - Are There Differences in Postoperative Pain Between Bupivacaine and Lidocaine for Carpal Tunnel Release? N/A
Completed NCT05023603 - Social and Cognitive Factors in Carpal Tunnel Syndrome
Terminated NCT00209560 - A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures Phase 3
Completed NCT04201652 - Comparing Superficial vs. Deep Local Anesthetic Infiltration to Improve Patient Experience During Carpal Tunnel Release N/A
Recruiting NCT06133712 - Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief N/A
Completed NCT03294733 - The Relationship Between Age and Carpal Tunnel Size N/A
Completed NCT02071238 - Factors Affecting Risk Recall in Open Carpal Tunnel Release Surgery N/A
Active, not recruiting NCT04504019 - Clinical Outcomes of USCTR vs. mOCTR N/A
Completed NCT03532373 - Testing of a Tool to Elicit Patient Preferences for CTS N/A
Completed NCT05405218 - Trial of Ultrasound Guided Carpal Tunnel Release Versus Traditional Open Release (TUTOR) N/A
Completed NCT04603274 - Efficacy of Electroacupuncture in Carpal Tunnel Syndrome N/A
Active, not recruiting NCT04235426 - Platelet Rich Plasma Injection Versus Surgical and Medical Treatment of Mild-moderate Carpel Tunnel Syndrome. Phase 1
Withdrawn NCT02666911 - Assessing the Comparability of 2D and 4D Ultrasound Measurements N/A
Terminated NCT02029235 - Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Phase 4
Completed NCT04924348 - WALANT Procedure in Carpal Tunnel Release N/A
Completed NCT05342870 - A Sequential Allocation Study to Determine the ED50 of Dexmetedomidine as an Adjuvant to Lidocaine Intravenous Regional Anesthesia N/A
Recruiting NCT04460521 - The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome Phase 4
Completed NCT05839769 - Evaluation of Carpal Tunnel Syndrome in Pregnancy
Completed NCT05343351 - Effect of Out of Plane and In Plane Injection Techniques in Patients With Carpal Tunnel Syndrome N/A